![Michael Batalia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Batalia
Director/Board Member at Kucera Pharmaceutical Co.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Louis Kucera | M | - |
Kucera Pharmaceutical Co.
![]() Kucera Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC.
Wake Forest University
| 54 years |
Matthew King | M | 65 |
Wake Forest School of Medicine
Wake Forest University
| - |
Mitesh B. Shah | M | 54 |
Wake Forest School of Medicine
Wake Forest University
| - |
Stephen R. Berlin | M | - |
Wake Forest University
| - |
Charles Iacovou | M | - |
Wake Forest University
| - |
Kim Westmoreland | M | - |
Wake Forest University
| - |
Troy McConnell | M | - |
Wake Forest University
| - |
Elizabeth Amato | F | 67 |
Wake Forest University
| - |
Brig Sorber | M | - |
Wake Forest University
| - |
Jane Brightwell | F | - |
Wake Forest University
| - |
Darryl L. Landis | M | - |
Wake Forest University
| - |
Matthew S. Cullinan | M | - |
Wake Forest University
| - |
Harold Rosser | M | 75 |
Wake Forest University
| - |
Stephen L. Wallenhaupt | M | - |
Wake Forest University
| - |
Roger Beahm | M | - |
Wake Forest University
| - |
David N. LaMond | M | - |
Wake Forest University
| - |
Boris Pasche | M | 63 |
Wake Forest University
| - |
Greg Keeley | M | - |
Wake Forest University
| - |
James Becton | M | - |
Wake Forest University
| - |
Louise Broyhill | F | - |
Wake Forest University
| - |
Janice Calloway | F | - |
Wake Forest University
| - |
Lisbeth Evans | F | - |
Wake Forest University
| - |
Elizabeth Domenech | F | - |
Wake Forest University
| - |
Martin Guthold | M | - |
Wake Forest University
| - |
Elizabeth J. Gatewood | M | - |
Wake Forest University
| 20 years |
Bradford B. Walters | M | - |
Kucera Pharmaceutical Co.
![]() Kucera Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC. | 22 years |
Peter Carlson | M | 60 |
Wake Forest University
| - |
Scott E. Reed | M | 75 |
Wake Forest University
| - |
Adelaide Sink | F | 75 |
Wake Forest University
| - |
Curtis Farmer | M | 61 |
Wake Forest University
| - |
William L. Marks | M | 80 |
Wake Forest University
| - |
Ronald E. Deal | M | 80 |
Wake Forest University
| 21 years |
Robert E. Greene | M | 73 |
Wake Forest School of Medicine
| - |
H. Culp | M | 60 |
Wake Forest University
| - |
Mark Leuchtenberger | M | 67 |
Wake Forest University
| - |
David W. Dupree | M | 71 |
Wake Forest University
| - |
Stephen Taylor Williams | M | 64 |
Wake Forest School of Medicine
| 17 years |
Eric Wiseman | M | 68 |
Wake Forest University
| - |
Andrew J. Schindler | M | 79 |
Wake Forest University
| - |
Richard A. Brenner | M | 60 |
Wake Forest School of Medicine
| - |
William G. Ward | M | 70 |
Wake Forest University
| - |
William Greene | M | - |
Wake Forest University
| - |
Thomas W. Bunn | M | 71 |
Wake Forest University
| 14 years |
Jack Lowden | M | 66 |
Wake Forest University
| - |
Donald C. Ingram | M | - |
Wake Forest University
| - |
Lars Nelson | M | 65 |
Wake Forest University
| - |
C. Nye | M | 61 |
Wake Forest University
| - |
Daniel M. Delen | M | 58 |
Wake Forest University
| - |
Patrick Thean | M | - |
Wake Forest University
| - |
Stan Meiburg | M | - |
Wake Forest University
| - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 50 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael Batalia
- Personal Network